Catalyst Event
Bristol-Myers Squibb Co (BMY) · Other
From Akros U.S. High Dividend 20 Index (AUHDIV20)
8/17/2026, 12:00:00 AM
The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of August 17, 2026, for its decision on iberdomide for relapsed or refractory multiple myeloma, scheduled. Low impact estimated as the target date is a procedural milestone.
Korean Translation
미국 식품의약국(FDA)이 재발성 또는 불응성 다발성 골수종 치료제 이버도마이드에 대한 처방약 사용자 수수료법(PDUFA) 목표 심사 완료일을 2026년 8월 17일로 지정함. 예정됨. 목표 심사일 지정은 절차적 일정으로 주가 영향은 제한적일 것으로 예상됨.
Related Recent Events
Blackstone Inc (BX) · Earnings Release
Blackstone is scheduled to release its Q2 2026 earnings results, with analysts forecasting earnings of approximately $1.34-$1.36 per share, scheduled.
7/23/2026, 12:00:00 AM
The Bank of Nova Scotia (BNS) · Earnings Release
Q2 2026 earnings results are scheduled for release before market open on May 27, 2026; medium impact is estimated due to typical earnings-related volatility, scheduled.
5/27/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Target's Q1 2026 earnings release is scheduled for 2026-05-20. Analysts forecast EPS of approximately $1.34. High importance is estimated based on typical earnings-related price swings forecasted.
5/20/2026, 12:00:00 AM
Manulife Financial Corp (MFC) · Other
Manulife Financial Corp. is expected to go ex-dividend around May 20-21, 2026. The payment date for the quarterly dividend is scheduled for June 19, 2026.
5/20/2026, 12:00:00 AM
Manulife Financial Corp (MFC) · Other
Manulife Financial Corp. will hold its annual meeting of common shareholders on May 14, 2026, scheduled.
5/14/2026, 12:00:00 AM
Manulife Financial Corp (MFC) · Earnings Release
Manulife Financial Corp. will release its first quarter 2026 financial results after markets close on Wednesday, May 13, 2026, scheduled.
5/13/2026, 12:00:00 AM